Form 483

Clearview Orthopedic Development Form 483, 2009-08-25

FDA issued a Form 483 to Clearview Orthopedic Development on 2009-08-25 with 10 public-safe observations.

483· Form 483 issued10 observations

Clearview Orthopedic Development · Irvine, United States · Issued August 25, 2009

Overview

  • 10 public-safe observations are available for this inspection.
  • 10 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

25 Aug 2009
21 CFR 803.50(a)(2)

Report of Malfunction

Cited by Donna L Besone

25 Aug 2009
21 CFR 820.25(a)

Sufficient personnel

Cited by Donna L Besone

25 Aug 2009
21 CFR 820.25(b)

Training

Cited by Donna L Besone

25 Aug 2009
21 CFR 820.30(b)

Establish the design and development plan

Cited by Donna L Besone

25 Aug 2009
21 CFR 820.50(a)

Evaluation of suppliers, contractors, etc., requirements

Cited by Donna L Besone

Inspected site

COClearview Orthopedic DevelopmentIrvine, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.50(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 820.160(a)Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 820.25(a)Cited across public-safe Form 483 observations1x
21 CFR 820.25(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(b)Cited across public-safe Form 483 observations1x
21 CFR 820.50(a)Cited across public-safe Form 483 observations1x
21 CFR 820.80(d)Cited across public-safe Form 483 observations1x
21 CFR 820.90(b)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 10 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere